Delivery Order SPE2DB22D1017-SPE2DB25FE7DU
Award Date
10/11/24
Potential Completion Date
10/15/24
Potential Value
$3.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $63,817.20 firm fixed-price delivery order is for the supply of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a pharmaceutical product. The contract has an ultimate completion date of June 12, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,570.20 firm fixed-price delivery order is for the BYDUREON BCISE 2 MG AUTOINJECT 0.85ML product, with a completion date of May 31, 2024. This award is a part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $13,204.36 for the delivery of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a medical product. The contract has an ultimate completion date of July 16, 2024 and is designated as a Firm Fixed Price contract. It is not associated with any set-aside requirements. Amerisourcebergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,057.04 firm-fixed-price delivery order is for the supply of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a medical product used in the treatment of certain health conditions. The contract has an ultimate completion date of February 11, 2025 and is not designated with a set-aside requirement, indicating open...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,662.45, is for the delivery of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is April 1, 2025. The contract has no set-aside designation, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,173.75, is a Delivery Order for the supply of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a pharmaceutical product. The contract has an ultimate completion date of December 23, 2024 and is a Firm Fixed Price contract. The contract was not designated with a set-aside. AmerisourceBergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The $44,155.01 firm fixed price delivery order is for the supply of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a pharmaceutical product. The award is associated with a larger indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,216.56 firm fixed-price delivery order is for the supply of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a medication used for the treatment of type 2 diabetes. The contract has an ultimate completion date of April 7, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,083.40 firm fixed price delivery order is for the supply of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML medical devices. The contract has an ultimate completion date of December 28, 2023 and was awarded on December 27, 2023. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $1,970.40 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide BYDUREON BCISE 2 MG AUTOINJECT 0.85ML. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical...